Lysergide

麦角乙二胺

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameLysergide
Drug Alias Namelysergide麦角二乙胺lysergidum麦角酸酰二乙胺lisergida +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsDepressive Disorder, MajorAnxietyCluster Headache +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsAustralia +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesThe University Hospital of Basel
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of FribourgMind Medicine IncRadboud University Medical Center +[6] 
Inactive CompaniesMultidisciplinary Association For Psychedelic Studies IncEleusis Therapeutics Ltd
Active IndicationsDepressive Disorder, MajorCluster HeadachePsychedelic
Inactive IndicationsAnxiety

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG